Back to Search Start Over

Improving antibody drug development using bionanotechnology

Authors :
Emily K Makowski
John S Schardt
Peter M Tessier
Source :
Curr Opin Biotechnol
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Abstract

Monoclonal antibodies are being used to treat a remarkable breadth of human disorders. Nevertheless, there are several key challenges at the earliest stages of antibody drug development that need to be addressed using simple and widely accessible methods, especially related to generating antibodies against membrane proteins and identifying antibody candidates with drug-like biophysical properties (high solubility and low viscosity). Here we highlight key bionanotechnologies for preparing functional and stable membrane proteins in diverse types of lipoparticles that are being used to improve antibody discovery and engineering efforts. We also highlight key bionanotechnologies for high-throughput and ultra-dilute screening of antibody biophysical properties during antibody discovery and optimization that are being used for identifying antibodies with superior combinations of in vitro (formulation) and in vivo (half-life) properties.

Details

ISSN :
09581669
Volume :
74
Database :
OpenAIRE
Journal :
Current Opinion in Biotechnology
Accession number :
edsair.doi.dedup.....cfdcf48c16e3aafcebe5dd9fce54c2b4